About Aptadir Therapeutics
Aptadir Therapeutics is developing a treatment for Myelodysplastic Neoplasms based on the capability of specific RNA therapeutics.
Sectors & Market Categories
Company Details
Corporate & Operational Profile
Primary Industry
Biotech & Healthcare
Funding Stage
Seed
Global Headquarters
Milan, Italy
Tracked Since
Oct 2, 2026
Web & Domain Identity
Official Website
aptadir.com
Domain Registered Date
Feb 13, 2024
Social & Network Presence
X / Twitter Profile
Not linked
LinkedIn Corporate
Not linked
Company Milestones & Timeline
- Capital Raise
Raised $45,000,000 · Seed
entarabi.com
- Milestone
Website domain registered
aptadir.com
Investors & Backers
4BIO Capital
Angelini Ventures
CDP Venture Capital
Club degli Investitori
Crescent Enterprises
Evotec
Extend
Indaco Venture Partners
Italian Angels for Biotech
Kerna Ventures
XGEN Venture
Funding History
Seed
· Sep 29, 2026
$45,000,000 entarabi.com
Founders & Leadership
Annalisa Di Ruscio
Founder
Work email & phone locked
Unlock →
Daniel G. Tenen
Founder
Work email & phone locked
Unlock →
Giovanni Amabile
CEO & Executive Chairman
Work email & phone locked
Unlock →
Marcin Kortylewski
Founder
Work email & phone locked
Unlock →
Vittorio de Franciscis
Founder
Work email & phone locked
Unlock →
Press Coverage & Sources
Recently Funded Biotech & Healthcare Startups
View allVitalls
vitalls.ai
Seed Abu Dhabi, United Arab Emirates · Oct 2026
Hexagon Bio
hexagonbio.com
Series-B+ Oct 2026
RefloDx
reflodx.com
Seed Kaysville, United States · Oct 2026
HeyVoli
heyvoli.com
Pre-Seed Bangalore, India · Oct 2026
CureBay
curebay.com
Series-B+ Bhubaneshwar, India · Oct 2026
4Tissue
4tissue.com
Series-A Ghent, Belgium · Oct 2026